Biomerics announced the acquisition of Dependable Plastics and creation of a new division — Biomerics Interventional Medical Plastics (IMP) Division. […]
Senate Democrats have renewed a push for drug pricing reforms, releasing on Wednesday proposed legislation along with a bill summary. […]
FRANKLIN LAKES, N.J., July 5, 2022 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Rishi Grover has been named executive vice president (EVP) and chief integrated supply chain officer for BD, effective July 7, 2022. In this role, Grover will have global responsibility for the […]
Healthcare providers can easily order Myriad’s genetic tests for the more than 250 million patients within Epic’s network […]
Transit Scientific achieved increased U.S. patent protection for their novel exoskeleton focal-force angioplasty technology using standard off-the-shelf peripheral transluminal angioplasty (PTA) balloons. […]
Premier CNS-Focused Research Facilities in California and New Jersey Join the CenExel Centers of Excellence Clinical Research Site Network […]
The Senate Health, Education, Labor and Pensions (HELP) Committee voted 13 to 9 on Tuesday to advance user fee reauthorization legislation. […]
HT-6184 is a novel NEK7/NLRP3 inhibitor […]
BD is among the first companies to enter innovative partnership with Mayo Clinic Platform for access to world’s largest collection of clinical data […]
CerTest Biotec Uses the BD MAX™ Molecular Diagnostic System Open System Reagent Suite to Develop RT-PCR Detection Kit […]
Expands BD Transformative Solutions to Provide New Pharmacy Automation Technologies for Hospitals, Retail Pharmacy, Long-Term Care and Home Settings Advances BD 2025 Strategy to Accelerate Innovation in Smart, Connected Care and Enable New Care Settings Expected to be Immediately Accretive to Revenue Growth, Adjusted Operating Margins and Adjusted EPS; Enhances Ability to Achieve Long-Range Sales […]
Data shared in oral presentation at American Diabetes Association 82nd Scientific Sessions® and published in Kidney360 highlights importance in early understanding of cardiovascular risk, a leading cause of death in patients with diabetes and chronic kidney disease […]